DiabetologNytt Nr 1-2-2025
Senaste Nr DiabetologNytt i PDF
Arkiv alla nyheter

ADA Report. Medtronic MiniMed 780G System and Next-Gen CGM Clinical Trials Now Enrolling Participants

The MiniMed 780G is the next iteration of the 670G hybrid closed loop system. Improvements and new features include automatic correction boluses, Bluetooth connectivity, remote software updating, a time-in-range goal greater than 80%, and an adjustable target blood glucose level down to 100 mg/dl. It will be enrolling up to 350 people with type 1 diabetes ages seven and up. 

Medtronic’s next-gen CGM will only require calibration on day one of the seven-day sensor. It will be enrolling up to 460 people with both type 1 and type 2 diabetes ages two and up. Read more here.

https://clinicaltrials.gov/ct2/show/NCT03966911

From www.diabtribe.org

Nyhetsinfo

www r ed DiabetologNytt

Facebook
LinkedIn
Email
WhatsApp